Invention Grant
- Patent Title: Treatment and prevention of Alzheimer's disease (AD)
-
Application No.: US17370615Application Date: 2021-07-08
-
Publication No.: US11857568B2Publication Date: 2024-01-02
- Inventor: Markus Mandler , Achim Schneeberger , Wolfgang Zauner , Arne Von Bonin , Frank Mattner , Walter Schmidt
- Applicant: Advantage Therapeutics, Inc.
- Applicant Address: US FL Fort Lauderdale
- Assignee: Advantage Therapeutics, Inc.
- Current Assignee: Advantage Therapeutics, Inc.
- Current Assignee Address: US FL Fort Lauderdale
- Agency: Foley Hoag LLP
- Agent Lucas P. Watkins; Alexander J. Chatterley
- Priority: EP 166355 2014.04.29 EP 166388 2014.04.29
- Main IPC: A61K33/06
- IPC: A61K33/06 ; A61K33/08 ; A61K33/42 ; A61K45/06
Abstract:
The invention discloses an aluminium salt for use in the treatment and prevention of dementias associated with β-amyloid deposition, preferably AD.
Public/Granted literature
- US20220000908A1 TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE (AD) Public/Granted day:2022-01-06
Information query
